Development of nanovax TM (oil in water nanoemulsion adjuvant) formulated allergens as intranasal immunotherapeutic vaccines for peanut allergy.
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93019C00035
- Awardee
-
Bluewillow Biologics Inc. UEI RL3UZ5ZDKFT8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,295,688
Award facts
- Opportunity
-
- PHS20191 Solicitation number
- Contract value 100% obligated
- $3,295,688.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 10 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Ann Arbor, MI 48105, USA
- Research
- SBIR Program Phase I Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Funding Only Action | $79,300 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $2,916,500 | |
| Change Order | $0 | |
| Original award | $299,888 |
Show all 13
About this award
This is a $3,295,688.00 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Bluewillow Biologics Inc., a small business. The contract is for the development of NanoVax, an oil-in-water nanoemulsion adjuvant formulated with allergens as intranasal immunotherapeutic vaccines for peanut allergy. This contract is part of the Small Business Innovation Research (SBIR) program and represents Phase I of the research and development effort. Bluewillow Biologics has also received over $7 million in NIAID grants for the development of a nanoemulsion-adjuvanted respiratory syncytial virus (RSV) vaccine, and has provided formulation and analytical services as a subrecipient on federal grants for tuberculosis vaccine development.
Quick answers
Who was awarded contract 75N93019C00035?
75N93019C00035 was awarded to Bluewillow Biologics Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 1, 2019.
How much is contract 75N93019C00035 worth?
The government has obligated $3,295,688 on 75N93019C00035.
Was contract 75N93019C00035 competed?
The extent of competition for 75N93019C00035 was full and open competition after exclusion of sources. The government received 10 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award